NCT06347159Phase 2Active not recruiting

A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)

Study sponsor: Edgewise Therapeutics, Inc. · EWTX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-12Estimated

Enrollment · participants79Estimated

Source updated2026-07-31Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-07-31 · 2 fields changed

Planned enrollment decreased by 21 participants

− Before

~~100 participants (planned)~~

+ After

79 participants (planned)

Primary completion date changed

− Before

~~Jun 2026~~

+ After

Dec 2027

Check registry source

Posted 2026-02-05 · 1 field changed

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source

Posted 2025-11-24 · 2 fields changed

Planned enrollment increased by 25 participants

− Before

~~75 participants (planned)~~

+ After

100 participants (planned)

Primary completion date changed

− Before

~~Mar 2026~~

+ After

Jun 2026

Check registry source